Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure
Clinical trial NCT05211167 · UNKNOWN
Trial details
- NCT number
- NCT05211167
- Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2023-06-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.